Advertisement
Endo International Narrows FY23 Revenue Outlook Range - Update
(RTTNews) - While reporting financial results for the second quarter on Tuesday, specialty pharmaceutical company Endo International plc (ENDPQ.PK) narrowed its revenue guidance range for the full-year 2023.
For fiscal 2023, the company now projects revenues between $1.975 billion and $2.035 billion, compared to the prior forecast range of $1.890 billion and $2.075 billion.
On average, analysts polled by Thomson Reuters expect the company to report revenues of $2.32 billion for the year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates
Dublin, Ireland -based Endo International plc announced that its operating company Par Pharmaceutical, Inc. is recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The recall, being conducted along with the U.S. Food and Drug Administration, is due to the potential for the presence of silicone particulates in the product solution.
RTTNews
|
442日前
Endo International Says Health Canada Approves XCOPRI To Treat Epilepsy
Specialty pharmaceutical company Endo International plc (ENDPQ.PK) announced Thursday that its operating company Paladin Labs, Inc. (PLB.TO) has received Health Canada's approval of XCOPRI (cenobamate tablets) for adjunctive therapy in the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy.
RTTNews
|
699日前
Endo Int'l Reports Top-line Results From Phase 2 Study Of CCH For Adhesive Capsulitis Of Shoulder
Pharmaceutical company Endo International plc (ENDP) announced Friday top-line results from its Phase 2 study of Collagenase Clostridium Histolyticum (CCH) in participants with adhesive capsulitis (AC) of the shoulder, commonly known as "frozen shoulder."
RTTNews
|
1062日前
Sensex, Nifty Modestly Higher; IT Stocks Lead Gains
Indian shares opened on a firm note Thursday after technology giant Nvidia buoyed investors with a bullish outlook for the growth in artificial intelligence and the U.S. Court of International Trade blocked President Trump's proposed "Liberation Day" tariffs, saying he had overstepped his authority.
RTTNews
|
12分前
Australian Market Slightly Trims Early Gains In Mid-market
The Australian market is slightly trimming its early gains in mid-market moves on Thursday, reversing the slight losses in the previous session, despite the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,400 level, with gains in energy and technology stocks partially offset by a mixed performance in mining and financial stocks.
RTTNews
|
1時9分前
Asian Markets Mostly Higher
Asian stock markets are trading mostly higher on Thursday, despite the broadly negative cues from Wall Street overnight, after a U.S. federal court blocked US President Donald Trump's attempt to impose sweeping reciprocal tariffs against its global trading partners under emergency powers, saying he exceeded his authority. Asian markets closed mostly lower on Wednesday.
RTTNews
|
1時29分前
Sensex, Nifty Seen Higher As US Court Blocks Trump's Tariffs
Indian shares look set to open higher on Thursday as investors react to encouraging industrial output data, upbeat Nvidia earnings and a U.S. court ruling blocking President Trump's "Liberation Day" tariffs, citing overreach of power.
RTTNews
|
2時4分前
Japanese Market Sharply Higher
The Japanese market is trading sharply higher on Thursday, extending the gains in the previous four sessions, despite the broadly negative cues from Wall Street overnight. The Nikkei 225 is moving above the 38,300 level, with gains across most sectors led by index heavyweights, exporters and technology stocks.
RTTNews
|
2時57分前
